Decon gel for radiological incidents

摘要

CBI Polymers, a division of Cellular Bioengineering Inc. (CBI), has announced the launch of its DeconGel~(TM) 1101 product. DeconGel~(TM) is an effective radiological decontamination solution available to industries worldwide ranging from nuclear power utilities, decommissioning and decontamination sites, hospital facilities, and research laboratories. The worldwide market is estimated to be $200 million per year.rnThe material effectively decontaminates a broad range of surfaces and contaminants. Its binding properties allow it to trap and encapsulate a wide spectrum of radioisotopes on different substrates in a simple, no-preparation process allowing easy and safe disposal without the use of water or cleaning agents. DeconGel~(TM) has been in beta testing for the past year, and has secured more than 30 customers around the world. Current customers include Ontario Power Generation, Washington Savannah River Company, Sandia National Laboratory, Lawrence Livermore National Laboratory, Colorado State University, and Tripler Army Medical Center.